Clonal Hematopoiesis Registry Providing a Step Toward Evidence-Based Guidelines | ASH Clinical News | American Society of Hematology
Katie Robinson is a medical writer based in New York. Patients with clonal hematopoiesis (CH) have an increased risk of hematologic malignancy and nonmalignant organ dysfunction, but CH management strategies remain lacking. To help develop guidelines to prevent these adverse outcomes, researchers have developed the prospective CHIVE registry and biorepository, with initial data published in Blood Advances. Linked to increasing age, CH presents as clonal hematopoiesis of indeterminate potential (CHIP), a